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Pterygium is a proliferative disease. Recent research has
reported that stem cells are involved in the pathogenesis of
various proliferative diseases, including solid tumors and
diabetic proliferate vitreoretinopathy. In previous literature,
we hypothesized that adult stem cells originated from bone
marrow were involved in the pathogenesis of pterygium. We
proved this by immunohistochemical staining with various
stem cell markers. The staining showed adult stem cells in
the pterygium. c-kit positive cells were observed primarily
in the stroma, and some cells were also found in the basal
epithelium. AC133 and CD34 positive cells were primarily
found in the basal epithelium and were ovoid shaped,
similar to the c-kit cells. However, some cells were found
in vascular endothelium. STRO-1 positive cells were found
mainly in the stroma and were spindle shaped. In recurrent
pterygium, cells were more scattered and the expression
pattern was denser. Therefore, we suggest a new theory of
pterygium pathogenesis. Inflammation caused by environ-
mental factors triggers the abnormal production of some
growth factors and cytokines in order to recover from
cellular damage. If these healing signals are excessive,
limbal basal cells will be changed to abnormally-altered
pterygial cells. The excessive wound healing process and
remnant altered cells result in recurrence using the same
mechanism.
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INTRODUCTION
Pterygium is a chronic condition characterized
by the invasion of altered ocular surface tissue
into the cornea.
1,2 The invasive cells show a trans-
formed epithelium and fibroblasts in the conjunc-
tiva.
3,4 Ultraviolet light (UV), dust, etc. are known
to be influential factors that induce this abnormal
change of cells in pterygium pathogenesis.
5 Until
now, two opposite concepts have been proposed
to explain pterygium pathogenesis. Pterygia have
some characteristics of a degenerative disorder,
such as elastoid and hyaline dystrophy, or thick-
ening of basement membrane.
6 However, pro-
liferative features, such as epithelial hyperplasia,
dys-generation of cell cycle related genes (high
expression rate of mutated 53 and bcl-2 onco-
gene), and s high recurrence rate after excision,
are also seen.
7-9 Recent research results suggest
that pterygium is a proliferative disease.
10,11 Al-
though this condition is well-studied, no studies
to date have clearly explained its pathogenesis
regarding the origin of cells and the mechanism
of its aggressive recurrence behavior after surgical
excision and the wound healing process.
Adult stem cells have several unique features.
The cells originate from differentiated tissues, in-
cluding bone marrow, and are capable of self-re-
newal. Thus, they can reproduce and proliferate
on their own in adequate conditions.
12-14 Recently,
it was discovered that stem cells are involved in
the pathogenesis of several proliferative diseases,
including hematologic neoplasm,
15 other solid
tumors,
16,17 paroxysmal nocturnal hemoglobinuria,
18,19 and proliferate vitreoretinopathy.
20
Based on these results, we hypothesized that
certain environmental stimuli may stimulate mul-
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tipotent bone marrow stem cells to gain the unex-
pected ability to proliferate and differentiate into
phenotypically and functionally unrelated cells to
the origin, then express various growth factors
and cytokines, affecting proliferation, tissue inva-
sion, and even recurrence of pterygium. There-
fore, we performed immunohistochemical staining
with various stem cell markers in pterygial tissues
to investigate the involvement of the bone mar-
row-originated stem cells in the pathogenesis,
progress, and recurrence of pterygium.
MATERIALS AND METHODS
Patient and specimen collection
All procedures were performed under the tenets
of the Helsinki declaration, and informed consent
was obtained from all patients. Twenty consecu-
tive pterygial tissues were obtained after surgical
removal of the pterygium (primary pterygium, n=
10; recurrent pterygium, n = 10; mean age 55.1
and 56.4, respectively). Normal conjunctival tis-
sues for the control group (n = 2) were obtained
from healthy donors without any ocular surface
disorders, such as allergies or dry eye. Paraffin
embedded samples were used for AC133, c-Kit,
and CD34. Snap-frozen sectioned tissues were
used for STRO-1. Serial cross sections were made
along the longitudinal axis so as to include the
leading edge.
Immunohistochemical staining
The avidin biotin complex technique was used
to stain the sectioned specimens (2-4 m). Paraffin μ
sections were deparaffinized in xylene, rehydrated
through decreasing ethanol grades, and quenched
for endogenous peroxidase. Cryostat sections
were placed on gelatinized slides, fixed in cold
acetone, and then rinsed in tris-buffered saline
(TBS). Nonspecific background was eliminated by
incubating tissue sections with non-immuno se-
rum (Zymed Laboratories, South San Francisco,
CA, USA, Histostatin-plus Kits, Reagent A). Sec-
tions were incubated with monoclonal mouse
anti-human AC133 antibody (Clone AC133 epi-
tope, Miltenyi Biotech, Bergisch Gadbach, Ger-
many), monoclonal mouse anti-human STRO-1
(DHBC, IA, USA), polyclonal goat anti-human
CD34 (N-19, Santa Cruz Biotechnology, Santa
Cruz, CA, USA), and polyclonal goat anti-human
c-Kit (C-14, Santa Cruz Biotechnology, Santa Cruz,
CA, USA) overnight at 4 , then extensively
washed in 0.05 M TBS (pH 7.6) before the addition
of a biotinylated secondary antibody (Reagent B).
Sections were washed again, incubated for 1 hour
with peroxidase-conjugated streptavidin (Reagent
C), and the presence of peroxidase was revealed
by adding substrate-chromogen (3-amino-9-ethy-
carbazole) solution (Reagent D). Sections were
counterstained with hematoxylin. Each section
was photographed, and the entire tissue area was
examined.
RESULTS
Upon light microscopic observation, abundant
progenitor cells originated from bone marrow
were seen in the basal epithelium or stroma of all
primary (n = 10) and recurrent (n = 10) pterygial
tissues. Positive immunoreactivity to progenitor
cell markers were mainly found along the entire
specimen axis, but were predominantly found in
the head portion of the pterygium.
CD34 positive cells were observed in the basal
epithelium of the pterygium, and cell shapes were
ovoid to round. The staining results of CD34 were
similar to those of c-kit in terms of the cell locali-
zation and expression pattern, but CD34 positive
cells were found around the perivascular endo-
thelium. Cell numbers and staining patterns were
more prominent in recurrent pterygia, compared
with the primary cases (Fig. 1. A-C).
c-Kit positive cells were observed not only in
the stroma but were also found in the basal
epithelium of the pterygium. Cell shapes were dif-
ferent from their stained sites. Cells observed in
the stroma showed fibroblast-like and spindle-
shaped morphology, whereas cells in the basal
epithelial layer were round to ovoid-shaped. c-kit
positive cells were not found in the normal
conjunctiva (Fig. 2A).
AC133 positive cells were observed mainly inInvolvement of Bone Marrow Stem Cells in Pterygium
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the epithelial layer, and some cells were scattered
in the stroma of the pterygium. Most cells were
ovoid-shaped. However, a few cells were spindle-
shaped and these cells were not found in the
normal conjunctiva. The sites of AC133 positive
cells were similar to c-kit, and cells showed the
same ovoid shape as CD34. Although the cell
shapes and cell numbers varied, AC133, CD34,
Fig. 1. Immunohistochemical staining of adult stem cells.
CD34 positive cells were observed mainly in the basal
epithelial portion of the pterygium (arrow). Cells were
found in the vascular endothelium in the stroma
(asterisk). Cell shapes were round to ovoid. In normal
conjunctiva, a few positive cells were found. Perivascular
endothelial cells were also positively stained (cross). (A:
normal conjunctiva; B, C: pterygium). (EP, epithelium;
STM, stroma) (A, B: × 200; C: × 400).
Fig. 2. Immunohistochemical staining of adult stem cells.
c-Kit positive cells were observed mainly in the stroma
and had a fibroblast like, spindle-shape (A: arrow).
AC133 positive cells were found in the basal epithelium
and stroma (B). STRO-1 positive cells were observed
mainly in the stroma and had a fibroblast-like, spindle
shape (C: asterisk). Cells in the basal epithelial layer of
the pterygium (C: arrow head, rhodanine staining) (EP,
epithelium; STM, stroma, × 200).
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and c-kit positive cells were co-expressed in basal
epithelium (Fig. 2B).
Spindle-shaped STRO-1 positive cells were
found in the stroma by rhodanine staining (Fig.
2C). Generally, in recurrent pterygia positively
stained sites and cell shapes were similar to those
of the primary cases. However, cell numbers and
expression patterns were more prominent in all
recurrent cases compared with primary pterygia
cases.
DISCUSSION
Adult stem cells originated from bone marrow
play an important role in the pathogenesis and
progression of various proliferative diseases.
15-20
This role may be direct, through its proliferation
or indirect, through the production of growth
factors and cytokines. This may then induce ad-
jacent cells to undergo unexpected propagation
and vegetation properties without limitation.
Pterygium is one of the major sight-threatening
conditions in developing countries. This condition
creates several problems, including dry eye, ir-
regular astigmatism, and unacceptable cosmetic
trouble.
1,2 Although some degenerative changes
were observed,
6 pterygium is considered a proli-
ferative disorder.
10,11 Many research results
support this proliferative classification. Various
growth factors and cytokines are expressed in the
pterygia. Similar expressions are also found in
some viral infections, such as those caused by the
human papilloma virus
11,21 and herpes simplex
virus.
22 These viral infections evoke gene mutation
in the pterygium.
As a result of immunohistochemical staining in
primary and recurrent pterygial tissue, various
mesenchymal, hematopoietic, and endothelial pro-
genitor cells were observed. c-Kit is identified on
the cellular surface and it represents receptors of
stem cell factor (SCF), also termed kit ligand, and
it augments the proliferation of primitive bone
marrow and mast cells. Positive staining for c-Kit
indicates a mesenchymal lineage progenitor. c-Kit
positive cells, found in the stroma and basal
epithelium, had a spindle-shaped, fibroblast-like
appearance. This suggested mesenchymal pro-
genitor cells. CD34 is known as the most common
marker for hematopoietic progenitor cells.
23 CD34
positive cells were expressed in the basal epithe-
lium and the peri-vascular endothelium. CD34
positive cells are hematopoietic precursors.
Though there is no direct relationship between
blood cells and pterygia, these hematopoietic
precursors have a supportive role in other pro-
genitor cells, such as mesenchymal lineages.
AC133 is a marker for endothelial progenitors and
neuronal stem cells. It is rapidly down-regulated
during differentiation.
24 AC133 positive cells were
observed in similar sites as CD34, and with the
same shape of round to ovoid. Based on the
patterns of the AC133 and CD34 positive cells, we
can suspect that these cells may be differentiated
into the endothelium. It is strongly supports the
above thought that AC133 and CD34 positive cells
were found mainly in the basal epithelium and
endothelium of small vessels of the stroma. STRO-
1 is known as a potent marker for mesenchymal
precursors.
25,26 Positively stained cells are fibro-
blast-like and spindle-shaped. The staining site
was overlapped in basal epithelium. This suggests
that one type of stem cells was activated by
another type of stem cells. Between each type of
stem cell, orchestrated mechanisms occurred for
migration and proliferation. As a result of stem
cell markers and cell morphology staining, we can
conclude that these cells were mesenchymal pre-
cursors and would be differentiated into fibro-
blasts, major transformed cells of the pterygium.
The fact that both endothelial and mesenchymal
lineages were involved in the progression of
pterygium explains the rich fibrovascular bundles
that encroached onto the cornea.
Generally, positive cells were found along the
entire specimen axis, but predominantly in the
head portion, which is known to be a very active
proliferative area in a pterygium. In recurrent
pterygia, they were more strongly expressed and
increased in stem cells - a more scattered expres-
sion pattern and an increase in cell numbers. Stem
cells were not found in control conjunctival tissue
(data not shown). These results also provided
strong evidence of stem cell involvement in ptery-
gium pathogenesis, especially dys-regulated, un-
controlled proliferation of affected cells.
From our results and previously reported re-
search, we propose a new theory for the patho-Involvement of Bone Marrow Stem Cells in Pterygium
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genesis and progression of pterygia. Stem cells are
involved in pterygial pathogenesis, and recur-
rence after surgical removal is caused by the in-
duction of abnormal differentiation and over-
proliferation of stem cells. Environmental factors
known to be associated with pterygium patho-
genesis, such as UV or dust, evoke inflammation
and cell damage.
5 These processes trigger the
overproduction of growth factors and cytokines,
such as TGF-β, IL-1β, IL-6, bFGF, IGFs, SCF, and
MMPs,
27-29 and conclusively enhance tissue remo-
deling. In this special ocular microenvironment,
limbal basal cells were changed to abnormal
pterygial cells and helped the encroachment of
these altered pterygial cells into the cornea.
During these processes, an unknown signal was
transmitted to the bone marrow in order to en-
hance the migration of stem cells into the dam-
aged ocular surface to repair damaged lesions via
a rich vascular arcade of limbus. As a result, the
healing process was activated and damaged
surface was recovered. However, the excessive
healing process led to the uncontrolled production
of growth factors and cytokines. Cellular altera-
tion into transformed epithelial cells and fibro-
blasts was observed in the pterygia, and finally,
the disease developed. Our results support these
conclusions. Moreover, from this hypothesis, one
can approximate the presence of not only pro-
moting factors, but also inhibitory factors for stem
cells. Stem cells act as a double edged-sword in
the healing process of a damaged ocular surface
- recover or disorder. Our findings also explain
the recurrent features of the pterygium after re-
moval. Surgical excision causes more iatrogenic
damages than environmental hazards on the ocu-
lar surface, and abundant growth factors and
cytokines are produced. If abnormal microenvi-
ronments still affect the wound healing process,
those products enhance cellular alteration, and
transformed cells may infiltrate the ocular surface.
Moreover, incomplete removal of altered cells
promotes these processes, and recurrence is fur-
ther accelerated. Therefore, stem cells may be an
indicator for pterygial recurrence. It is reasonable
to believe that larger numbers stem cells cause a
higher recurrence rate of pterygia after removal.
The complete removal of altered cells is essential
to prevent recurrence of pterygium.
In this study, we proved that bone marrow
originated stem cells are involved in pterygium
pathogenesis, progression, and recurrence. This is
a new idea and an important finding for ptery-
gium pathophysiology. However, we revealed
only a small portion of information related to
pterygial pathogenesis, and pterygium still re-
mains to be an ophthalmic enigma. Additional
research studying factors that enhance or inhibit
stem cells and triggering signals to bone marrow
must be undertaken to further elucidate pterygial
pathogenesis and to develop effective treatment
methods without recurrence.
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